Pathological Metabolism of Methionine in Malignant Cells Is a Potential Target for the Antitumor Therapy

Abstract

This review presents the characteristics of the cellular metabolism of methionine, as well as known data on the mechanisms of the development of methionine dependence in malignant cells. The possibilities of using a non-methionine diet for the control of the tumor growth in patients with various forms of cancer are considered. The information about methionine Y-lyase, an enzyme providing elimination of methionine from plasma, is provided. Its role as a potential antitumor enzyme is disclosed. Data on cytotoxic activity of the enzyme, obtained from various sources, and information on tumor models and cell cultures, showing methionine dependence are summarised.

Biotechnological aspects of the modification of secondary collagen-containing raw materials – tripe for the production of cost-effective functional meat products

“…In the vast majority of cases, because of this, peptides are deprived of their biological activity. One of the most promising ways to control tumor growth may be the use of enzymes that reduce the concentration of certain amino acids in plasma, in particular, asparagine, arginine, phenylalanine, and methionine (Pokrovskii et al, 2017). In this sense, "Sheki" semi-smoked sausage is one of the most promising means of protecting people from radiation.…”